We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
+15.86%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$219M
AUM Growth
+$95.8M
(+78%)
Cap. Flow
+$80.7M
Cap. Flow
% of AUM
36.91%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
163
New
55
Increased
48
Reduced
23
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$32.3M |
| 2 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$3.42M |
| 3 |
TXNM
TXNM Energy Inc
TXNM
|
+$3.29M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$3.26M |
| 5 |
Indivior Pharmaceuticals
INDV
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$4.25M |
| 2 |
Coupang
CPNG
|
+$4.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
+$3.46M |
| 4 |
TGNA
TEGNA Inc
TGNA
|
+$2.44M |
| 5 |
First Horizon
FHN
|
+$2.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.57% |
| 2 | Technology | 13.44% |
| 3 | Communication Services | 5.29% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
GE Aerospace
GE
$380B
| $749K | 0.34% |
+8,547
| New | +$692K |
|
77
United Parks & Resorts
PRKS
$2B
| $744K | 0.34% |
+13,288
| New | +$750K |
|
78
Occidental Petroleum
OXY
$58.6B
| $732K | 0.33% |
+12,447
| New | +$747K |
|
79
HCA Healthcare
HCA
$89.6B
| $732K | 0.33% |
+2,411
| New | +$670K |
|
80
Vaxcyte
PCVX
$8.67B
| $727K | 0.33% |
14,561
-5,045
| -26% | -$239K |
|
81
Netflix
NFLX
$318B
| $724K | 0.33% |
16,440
+9,540
| +138% | +$351K |
|
82
Liberty Global Class C
LBTYK
$3.41B
| $723K | 0.33% |
+40,664
| New | +$758K |
|
|
VRNA
83
DELISTED
Verona Pharma
VRNA
| $719K | 0.33% |
34,027
-13,696
| -29% | -$292K |
|
84
Transocean
RIG
$6.39B
| $717K | 0.33% |
+102,325
| New | +$633K |
|
|
JBIO
85
Jade Biosciences
JBIO
$1.32B
| $717K | 0.33% |
1,194
+742
| +164% | +$475K |
|
86
Charter Communications
CHTR
$18.3B
| $710K | 0.33% |
+1,934
| New | +$660K |
|
87
Syndax Pharmaceuticals
SNDX
$1.82B
| $703K | 0.32% |
33,576
+7,972
| +31% | +$166K |
|
88
Adobe
ADBE
$109B
| $697K | 0.32% |
+1,425
| New | +$574K |
|
89
argenx
ARGX
$54.2B
| $693K | 0.32% |
1,778
-555
| -24% | -$218K |
|
90
BioMarin Pharmaceuticals
BMRN
$13.3B
| $693K | 0.32% |
7,993
-1,708
| -18% | -$161K |
|
91
FirstService
FSV
$6.27B
| $692K | 0.32% |
+4,491
| New | +$653K |
|
92
Acadia Pharmaceuticals
ACAD
$5.06B
| $690K | 0.32% |
28,791
-26,783
| -48% | -$595K |
|
93
Sea Limited
SE
$70.3B
| $687K | 0.31% |
+11,841
| New | +$845K |
|
94
HDFC Bank
HDB
$120B
| $686K | 0.31% |
19,682
+12,182
| +162% | +$411K |
|
|
CIVI
95
DELISTED
Civitas Resources
CIVI
| $683K | 0.31% |
+9,849
| New | +$681K |
|
96
ICICI Bank
IBN
$108B
| $682K | 0.31% |
29,547
+17,387
| +143% | +$393K |
|
97
MSCI
MSCI
$40.9B
| $680K | 0.31% |
1,448
+948
| +190% | +$462K |
|
98
StoneCo
STNE
$2.52B
| $679K | 0.31% |
+53,330
| New | +$665K |
|
99
TransDigm Group
TDG
$67.6B
| $679K | 0.31% |
+759
| New | +$600K |
|
100
Incyte
INCY
$24.6B
| $677K | 0.31% |
10,879
| – | – |
|
Similar funds
SIAG
MS
WI
WTFG
VIA
A6
PI
ACM
HighVista Strategies's Q2 2023 Portfolio in Review
As of Q2 2023, HighVista Strategies held 163 positions worth $219M, up 78% from $123M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
HighVista Strategies deployed $80.7M of net new capital in Q2 2023, opening 55 new positions and adding to 48 existing holdings. Its largest new stake was Aerojet Rocketdyne Holdings: 61,520 shares worth $3.38M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 67% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Travere Therapeutics, an estimated $1.75M trimmed.
- HighVista Strategies's largest Q2 2023 buy was Aerojet Rocketdyne Holdings: 61,520 shares worth $3.38M.
- HighVista Strategies added most to Invesco DB Commodity Index Tracking Fund in Q2 2023, an estimated $32.3M increase.
- HighVista Strategies's biggest Q2 2023 reduction was Travere Therapeutics, cutting an estimated $1.75M.
- HighVista Strategies fully exited iShares Russell 1000 Value ETF in Q2 2023, selling an estimated $4.25M.
- HighVista Strategies's ten largest holdings make up 34% of its $219M portfolio in Q2 2023.
- HighVista Strategies opened 55 new positions and closed 29 in Q2 2023.
- HighVista Strategies's portfolio value rose 78% quarter-over-quarter to $219M.
Based on HighVista Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.